|SAS is the leader in analytics. Through innovative analytics, business intelligence and data management software and services, SAS helps customers at more than 80,000 sites make better decisions faster. Since 1976, SAS has been giving customers around the world THE POWER TO KNOW®.|
|Pfizer funds programs that provide public benefit, advance medical care and improve patient outcomes. We believe all people deserve to live healthy lives. This drives our desire to provide access to medicines that are safe, effective, and affordable.
The Global Biometrics & Data Management (GBDM) team’s vision is to be the preferred collaborative partner for harnessing the power of data to drive robust evidence-based decision-making and shaping the scientific and healthcare environment. Our Statistical Programming & Analysis (SPA) team’s mission is to predictably deliver and manage data as a strategic asset to the highest ethical and regulatory standards. We are growing rapidly and are recruiting for statistical programmers at all levels. To apply, visit pfizer.com/careers and search for “Statistical Programming”.
|SAS® users and organizations around the world use Metacoda Plug-ins to maintain a secure SAS platform through efficient and productive metadata management. Our software helps SAS platform administrators to regularly manage, review, troubleshoot, document, test and audit their SAS platform installation with confidence.|
|Oracle Cloud Infrastructure is a Generation 2 IaaS and PaaS cloud that enables enterprises to securely run mission-critical enterprise application and database workloads with unmatched performance and the strongest service-level agreements (SLAs) in cloud computing. Oracle Cloud Infrastructure is a set of complementary cloud services that enable you to build and run a wide range of applications and services in a highly available hosted environment. Oracle Cloud Infrastructure offers high-performance compute capabilities (as physical hardware instances) and storage capacity in a flexible overlay virtual network that is securely accessible from your on-premises network.|
|Axio Research was founded in 1979 as a corporation dedicated to scientific advancement and discovery. Our founders are internationally recognized experts in the fields of biostatistics, epidemiology, and medicine. During the past two decades, Axio’s range of services has encompassed both government-sponsored clinical trials and contract research services for commercial clients. We draw from our pool of biostatisticians, project managers, data technicians, and SAS programmers to create a team whose collective experience best fits a client’s needs.|
|Catalyst Clinical Research, through our merger with Triangle Biostatistics, is an innovative biometrics service provider including biostatistics, statistical programming, FSP solutions, data management, and consulting services. Catalyst biometrics was originally founded to provide statistics and programming services to the pharmaceutical industry, it is the foundation of everything we do. The experience of our team is unparalleled in the industry. With extensive experience in all phases of drug development and numerous regulatory submissions across various indications, Catalyst is positioned to provide strong biometrics services utilizing sound scientific reasoning and the latest computing technology.|
|SDC delivers top-tier clinical trial services to pharmaceutical, biologic, and medical device/diagnostic companies since 2005. We are committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects. With strategic scientific consulting and clinical data services expertise (biostatistics, data management/EDC, and IRT/IWRS) at our core, our services are scalable via our diverse and complementary strategic partnerships to provide full service clinical trial solutions. Speak with us today to see why SDC is The Right Fit for You.|
|Seattle Genetics is an emerging multi-product, global biotechnology company and the largest based in the Pacific Northwest. We develop and commercialize transformative therapies targeting cancer to make a meaningful difference in people’s lives. ADCETRIS® (brentuximab vedotin) utilizes the company’s industry-leading antibody-drug conjugate (ADC) technology and is approved for the treatment of multiple CD30-expressing lymphomas.
With multiple global product opportunities, significant research into advancing ADC technology and an emerging complementary immuno-oncology technology, we are positioned to transform cancer therapy.
|Accredited by AACSB International, Oklahoma State University’s Spears School of Business provides several graduate level analytics degree and certificate options (online and on-campus) including M.S. in Business Analytics and Data Science, Graduate Certificate in Business Data Mining, Graduate Certificate in Marketing Analytics and Graduate Certificate in Health Care Analytics.|
|As the third largest Department of Statistics in the US with a history and tradition of graduate education dating back to the 1960’s, the Department of Statistics at Texas A&M University offers an Online Master of Science in Statistics Degree, as well as Certificates with emphasis in Data Mining.|